Cardiovascular Disease Risk Reduction with Sleep Apnea Treatment

Overview

Journal Expert Rev Cardiovasc Ther

Specialty Cardiology & Vascular Diseases

Date 2010 Jul 7

PMID 20602560

Citations 13

Authors

Girardin Jean-Louis

Clinton D Brown

Ferdinand Zizi

Gbenga Ogedegbe

Carla Boutin-Foster

Joseph Gorga

Samy I McFarlane

Affiliations

Soon will be listed here.

Abstract

Cardiovascular diseases are the leading cause of death among adults in developed countries. An increase in prevalent cardiovascular risk factors (e.g., obesity, hypertension and diabetes) has led to a concerted effort to raise awareness of the need to use evidence-based strategies to help patients at risk of developing cardiovascular disease and to reduce their likelihood of suffering a stroke. Sleep apnea has emerged as an important risk factor for the development of cardiovascular disease. Epidemiologic and clinical evidence has prompted the American Heart Association to issue a scientific statement describing the need to recognize sleep apnea as an important target for therapy in reducing cardiovascular disease risks. This article examines evidence supporting associations of sleep apnea with cardiovascular disease and considers evidence suggesting cardiovascular risk reductions through sleep apnea treatment. Perspectives on emerging therapeutic approaches and promising areas of clinical and experimental research are also discussed.

Citing Articles

Linking Sleep Disorders to Atrial Fibrillation: Pathways, Risks, and Treatment Implications.

Ferreira M, Oliveira M, Laranjo S, Rocha I Biology (Basel). 2024; 13(10).

PMID: 39452070 PMC: 11504130. DOI: 10.3390/biology13100761.

Recent Advances in the Management of Non-rheumatic Atrial Fibrillation: A Comprehensive Review.

Kadam A, Kotak P, Khurana K, Toshniwal S, Daiya V, Raut S Cureus. 2024; 16(7):e65835.

PMID: 39219967 PMC: 11363501. DOI: 10.7759/cureus.65835.

The Impact of Intermittent Hypoxemia on Left Atrial Remodeling in Patients with Obstructive Sleep Apnea Syndrome.

Chen Y, Chen Y, Wang H, Chang Y, Fang Y, Hsueh S Life (Basel). 2022; 12(2).

PMID: 35207436 PMC: 8874769. DOI: 10.3390/life12020148.

Stratifying the Risk of Cardiovascular Disease in Obstructive Sleep Apnea Using Machine Learning.

Gourishetti S, Taylor R, Isaiah A Laryngoscope. 2021; 132(1):234-241.

PMID: 34487556 PMC: 8671206. DOI: 10.1002/lary.29852.

Perioperative complications in patients with sleep apnea following primary total shoulder arthroplasty: An analysis of 33,366 patients.

Wang C, Palmer J, Madden M, Cohen-Levy W, Vakharia R, Roche M J Orthop. 2019; 16(5):382-385.

PMID: 31110398 PMC: 6512835. DOI: 10.1016/j.jor.2019.04.003.

References

Shahar E, Whitney C, Redline S, Lee E, Newman A, Nieto F . Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001; 163(1):19-25. DOI: 10.1164/ajrccm.163.1.2001008. View

Dixon J, Schachter L, OBrien P . Polysomnography before and after weight loss in obese patients with severe sleep apnea. Int J Obes (Lond). 2005; 29(9):1048-54. DOI: 10.1038/sj.ijo.0802960. View

Young T, Peppard P, Palta M, Hla K, Finn L, Morgan B . Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med. 1997; 157(15):1746-52. View

Harsch I, Hahn E, Konturek P . Insulin resistance and other metabolic aspects of the obstructive sleep apnea syndrome. Med Sci Monit. 2005; 11(3):RA70-5. View

Coccagna G, Mantovani M, Brignani F, PARCHI C, Lugaresi E . Tracheostomy in hypersomnia with periodic breathing. Bull Physiopathol Respir (Nancy). 1972; 8(5):1217-27. View

Grundy S . A constellation of complications: the metabolic syndrome. Clin Cornerstone. 2006; 7(2-3):36-45. DOI: 10.1016/s1098-3597(05)80066-3. View

Tasali E, Ip M . Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation. Proc Am Thorac Soc. 2008; 5(2):207-17. DOI: 10.1513/pats.200708-139MG. View

Punjabi N, Sorkin J, Katzel L, Goldberg A, Schwartz A, Smith P . Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med. 2002; 165(5):677-82. DOI: 10.1164/ajrccm.165.5.2104087. View

Einhorn D, Stewart D, Erman M, Gordon N, Philis-Tsimikas A, Casal E . Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus. Endocr Pract. 2007; 13(4):355-62. DOI: 10.4158/EP.13.4.355. View

10.

Sanner B, Konermann M, Doberauer C, Weiss T, Zidek W . Sleep-Disordered breathing in patients referred for angina evaluation--association with left ventricular dysfunction. Clin Cardiol. 2001; 24(2):146-50. PMC: 6654824. DOI: 10.1002/clc.4960240209. View

11.

Kajaste S, Brander P, Telakivi T, Partinen M, Mustajoki P . A cognitive-behavioral weight reduction program in the treatment of obstructive sleep apnea syndrome with or without initial nasal CPAP: a randomized study. Sleep Med. 2004; 5(2):125-31. DOI: 10.1016/j.sleep.2003.07.007. View

12.

Stoohs R, Guilleminault C, Itoi A, Dement W . Traffic accidents in commercial long-haul truck drivers: the influence of sleep-disordered breathing and obesity. Sleep. 1994; 17(7):619-23. View

13.

Stamler J, Wentworth D, Neaton J . Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA. 1986; 256(20):2823-8. View

14.

Harris M . Diabetes in America: epidemiology and scope of the problem. Diabetes Care. 1998; 21 Suppl 3:C11-4. DOI: 10.2337/diacare.21.3.c11. View

15.

STROBEL R, Rosen R . Obesity and weight loss in obstructive sleep apnea: a critical review. Sleep. 1996; 19(2):104-15. DOI: 10.1093/sleep/19.2.104. View

16.

Gami A, Pressman G, Caples S, Kanagala R, Gard J, Davison D . Association of atrial fibrillation and obstructive sleep apnea. Circulation. 2004; 110(4):364-7. DOI: 10.1161/01.CIR.0000136587.68725.8E. View

17.

Lavie L . Obstructive sleep apnoea syndrome--an oxidative stress disorder. Sleep Med Rev. 2003; 7(1):35-51. DOI: 10.1053/smrv.2002.0261. View

18.

Chesson Jr A, Ferber R, Fry J, Hartse K, Hurwitz T, Johnson S . The indications for polysomnography and related procedures. Sleep. 1997; 20(6):423-87. DOI: 10.1093/sleep/20.6.423. View

19.

Hung J, Whitford E, PARSONS R, Hillman D . Association of sleep apnoea with myocardial infarction in men. Lancet. 1990; 336(8710):261-4. DOI: 10.1016/0140-6736(90)91799-g. View

20.

Tan K, Chow W, Lam J, Lam B, Wong W, Tam S . HDL dysfunction in obstructive sleep apnea. Atherosclerosis. 2005; 184(2):377-82. DOI: 10.1016/j.atherosclerosis.2005.04.024. View